Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2006 December; 7(4): E133–E140.
Published online 2014 March 30. doi:  10.1208/pt0704103
PMCID: PMC2750340

Chargeability measurements of selected pharmaceutical dry powders to assess their electrostatic charge control capabilities


The purpose of this study was to develop an instrument (the Purdue instrument) and the corresponding methodologies to measure the electrostatic charge development (chargeability) of dry powders when they are in dynamic contact with stainless steel surfaces. The system used an inductive noncontact sensor located inside an aluminum Faraday cage and was optimized to measure the charging capabilities of a fixed volume of powder (0.5 cc). The chargeability of 5,5-diphenyl-hydantoin, calcium sulfate dihydrate, cimetidine, 3 grades of colloidal silicon dioxide, magnesium stearate, 4 grades of microcrystalline cellulose, salicylic acid, sodium carbonate, sodium salicylate, spray-dried lactose, and sulfin-pyrazone were tested at 4 linear velocities, and the particle size distribution effect was assessed for 3 different grades of colloidal silicon dioxide and 4 different grades of micro-crystalline cellulose. The chargeability values exhibited a linear relationship for the range of velocities studied, with colloidal silicon dioxide exhibiting the maximum negative chargeability and with spray-dried lactose being the only compound to exhibit positive chargeability. The instrument sensitivity was improved by a factor of 2 over the first generation version, and the electrostatic charge measurements were reproducible with relative standard deviations ranging from nondetectable to 33.7% (minimum of 3 replicates). These results demonstrate the feasibility of using the Purdue instrument to measure the electrostatic charge control capabilities of pharmaceutical dry powders with a reasonable level of precision.

Keywords: Powders, charge control, electrostatic, chargeability, triboelectricity, excipients

Full Text

The Full Text of this article is available as a PDF (223K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Bailey AG, Hashish AH, Williams TJ. Drug delivery by inhalation of charged particles. J Electrostatics. 1998;44:3–10. doi: 10.1016/S0304-3886(98)00017-5. [Cross Ref]
2. Lucas P, Anderson K, Potter UJ, Staniforth JN. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm Res. 1999;16:1643–1647. doi: 10.1023/A:1011981326827. [PubMed] [Cross Ref]
3. Zeng XM, Martin GP, Marriot C. Particulate Interactions in Dry Powder Formulations for Inhalations. New York, NY: Taylor and Francis; 2001.
4. Staniforth JN, Rees JE. Electrostatic charge interactions in ordered powder mixes. J Pharm Pharmacol. 1982;34:69–76. doi: 10.1111/j.2042-7158.1982.tb04188.x. [PubMed] [Cross Ref]
5. Carter PA, Rowley G, Fletcher EJ, Hill EA. An experimental investigation of triboelectrification in cohesive and non-cohesive pharmaceutical powders. Drug Dev Ind Pharm. 1992;18:1505–1526. doi: 10.3109/03639049209040855. [Cross Ref]
6. Rogers B. Difficulties associated with compounding metered-dose inhalers and dry powder inhalers [Powerpoint presentation]. U.S. FDA, Center for Drug Evaluation and Research, Office of New Drug Chemistry, Pharmacy Compounding Advisory Committee. Available at: Accessed: July 19, 2003.
7. Wade EA, Weller PJ, editors. Handbook of Pharmaceutical Excipients. 2nd ed. Washington, DC: American Pharmaceutical Association; 1994.
8. Cabot Corporation . Cab-O-Sil untreated fumed silica properties and functions [catalog no. TD-100] Tuscola, IL: Cabot Corporation; 1993.
9. Bavin PMG, Post A, Zarembo JE. Cimetidine. In: Florey K, editor. Analytical Profiles of Drug Substances. Orlando, FL: Academic Press; 1984.
10. Kibbe AH, editor. Handbook of Pharmaceutical Excipients. 3rd ed. Washington, DC: Pharmaceutical Press; 2000.
11. Pujara CP. Determination of Factors That Affect the Generation of Airborne Particles From Bulk Pharmaceutical Powders. West Lafayette, IN: Industrial and Physical Pharmacy, Purdue University; 1997.
12. Abounassif MA, Mian MS, Mian AA. Salicylic acid. In: Brittain H, editor. Analytical Profiles of Drug Substances. Orlando, FL: Academic Press; 1994.
13. Sodium Salicylate MSDS. Available at: sodium_salicylate.txt. Accessed: July 19, 2003.
14. Monograph 8541. Sodium Carbonate. In: Budavary S, ed. The Merck Index. 11th ed. Whitehouse Station, NJ: Merck & Co; 1989.
15. Ghosh R. Pharmaceutical Powder Chargeability and Dustiness Characterization. West Lafayette, IN: Purdue University; 1997.
16. Gajewski JB, Szaynok A. Charge measurement of dust particles in motion. J Electrostatics. 1981;10:229–234. doi: 10.1016/0304-3886(81)90047-4. [Cross Ref]
17. USI . US Pharmacopeia National Formulary. Rockville, MD: USP; 1999.
18. Eilbeck J, Rowley G, Carter PA, Fletcher EJ. Effect of contamination of pharmaceutical equipment on powder triboelectrification. Int J Pharm. 2000;195:7–11. doi: 10.1016/S0378-5173(99)00351-8. [PubMed] [Cross Ref]
19. Murtomaa M, Harjunen P, Mellin V, Lehto V-P, Laine E. Effect of amorphicity on the triboelectrification of lactose powder. J Electrostatics. 2002;56:103–110. doi: 10.1016/S0304-3886(02)00066-9. [Cross Ref]
20. Reis GE, Bierly JN, Schwartz JB. Characterizing electrostatic charge in pharmaceutical powders. Am J Pharm. 1984;156:100–105.
21. Watano S, Suzuki T, Taira T, Miyanami K. Continuous monitoring and mechanism of electrostatic charge of powder in fluidized bed process. Chem Pharm Bull (Tokyo) 1998;46:1438–1443. doi: 10.1248/cpb.46.1438. [Cross Ref]
22. Murtomaa M, Rasanen E, Rantanen J, et al. Electrostatic measurements on a miniaturized fluidized bed. J Electrostatics. 2003;57:91–106. doi: 10.1016/S0304-3886(02)00121-3. [Cross Ref]
23. Swaminathan V, Kildsig DO. Effect of particle morphology on the physical stability of pharmaceutical powder mixtures: effect of surface roughness of the carrier on the stability of ordered mixtures. Drug Dev Ind Pharm. 2000;26:365–373. doi: 10.1081/DDC-100101242. [PubMed] [Cross Ref]
24. Bennett FS, Carter PA, Rowley G, Dandiker Y. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles. Drug Dev Ind Pharm. 1999;25:99–103. doi: 10.1081/DDC-100102148. [PubMed] [Cross Ref]
25. Zhao H, Castle GSP, Inculet II. The measurement of bipolar charge in polydisperse powders using a vertical array of Faraday pail sensors. J Electrostatics. 2002;55:261–278. doi: 10.1016/S0304-3886(01)00209-1. [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists